View in EDS PDF Full Text

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

Saved in:
Bibliographic Details
Title: Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.
Authors: Apostolou, Paraskevi1 (AUTHOR) apostoloup@rrp.demokritos.gr, Dellatola, Vasiliki1 (AUTHOR) v.dellatola@rrp.demokritos.gr, Papathanasiou, Athanasios1 (AUTHOR) t.papathanasiou@rrp.demokritos.gr, Kalfakakou, Despoina2 (AUTHOR) despoina.kalfakakou@nyulangone.org, Fountzilas, Elena3,4 (AUTHOR) fountzila@oncogenome.gr, Tryfonopoulos, Dimitrios5 (AUTHOR) oncology2@agsavvas-hosp.gr, Karageorgopoulou, Sofia6 (AUTHOR) skarageorgopoulou@iaso.gr, Yannoukakos, Drakoulis1 (AUTHOR) yannouka@rrp.demokritos.gr, Konstantopoulou, Irene1 (AUTHOR) reena@rrp.demokritos.gr, Fostira, Florentia1 (AUTHOR) florentia@rrp.demokritos.gr
Source: Cancers. Jul2024, Vol. 16 Issue 13, p2368. 12p.
Database: Academic Search Ultimate
Description
ISSN:20726694
DOI:10.3390/cancers16132368